Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

The new symptoms of the COVID period that CDAHK doctors have uncovered

HONG KONG, Jan. 10, 2022 /PRNewswire/ -- As the COVID-19 Omicron variety continues to spread, chiropractors see a spike in neck pathology from work-from-home, remote learning during pandemic. For 30 years before the COVID-19 pandemic, the majority of chiropractic patients were suffering from bac...

2022-01-10 23:52 1792

The new symptoms of the COVID period that CDAHK doctors have uncovered

Cyclone Robotics Was Recognized as a "Strong Performer" by the "Gartner Peer Insights 'Voice of the Customer': Robotic Process Automation" Report

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Recently, the world's authoritative technology research and analysis organization Gartner published the report "Gartner Peer Insights 'Voice of the Customer': Robotic Process Automation". Cyclone Robotics was the featured highlight in the report and was nam...

2022-01-10 22:01 2014

New Resource from NCCN Shares Evidence-Based Approaches to Recognize and Manage Graft-Versus-Host Disease after Stem Cell Transplantation

PLYMOUTH MEETING, Pa., Jan. 10, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines for Patients®: Graft-Versus-Host Disease (GVHD). GVHD is a complication that occurs after a donor stem cell or bone marrow (a.k.a. hematopo...

2022-01-10 21:37 1600

New Resource from NCCN Shares Evidence-Based Approaches to Recognize and Manage Graft-Versus-Host Disease after Stem Cell Transplantation

Everest Medicines Will Participate in a Clinical Trial with Gilead and MSD to Evaluate Trodelvy® in Combination with KEYTRUDA® (pembrolizumab) in First-Line Metastatic Non-Small Cell Lung Cancer

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), today announced it will participate in a study pursuant to a clinical trial collaboration between Gilead and MSD (Merck & Co., Inc., Kenilworth, N...

2022-01-10 21:35 3013

Clinical study on Bactiguard's endotracheal tube now published - shows significant reduction of ventilator-associated pneumonia

STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care. The study shows a 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube. It was presented for th...

2022-01-10 20:57 1582

Taiwanese Businesses Achieves Growth Through Digitalization

TAIPEI, Jan. 10, 2022 /PRNewswire/ -- When the global health crisis struck, the Taiwanese government made swift and decisive actions to curb and contain the situation and this has led to the Taiwanese economy to remain stable. SMEs have reported that even with the movement restrictions, they are ...

2022-01-10 16:10 1986

Taiwanese Businesses Achieves Growth Through Digitalization

Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report

Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma Report also examines key therapeutic development areas to watch including mRNA, CRISPR, AI-driven drug discovery and more LONDON, Jan. 10, 2022 /...

2022-01-10 16:00 2510

JW Therapeutics Announces Two Appointments to Strengthen R&D Capability and Pipeline Building

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, recently announced the appointments of Dr.Shaun Paul Cordoba as Chief Scientific Officer (...

2022-01-10 09:30 3011

Ascletis Announces U.S. IND Filing for In-House Developed Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors

HANGZHOU, China and SHAOXING, China, Jan. 10, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) announces today the filing of the U.S. Investigational New Drug (IND) application for in-house developed oral PD-L1 small molecule inhibitor, ASC61, for the treatment of advanced solid tumors. AS...

2022-01-10 08:30 2932

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

TIANJIN, China, Jan. 9, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that the National Medical Products Administration ofChina ("NMPA") granted approval for its ACYW135 Meningococcal Conjugate Vaccine (CRM197) ("MCV4", trade name: Menhycia™), ma...

2022-01-09 10:09 3580

Healthcare providers can expect to receive US$725 reimbursement from CMS when using NGS-based Sentosa(R) SQ HIV-1 Genotyping Assay

FAIRFIELD, N.J., Jan. 7, 2022 /PRNewswire/ -- Vela Diagnostics announced that itsSentosa® SQ HIV-1 Genotyping Assay is covered for reimbursement from The Centers for Medicare and Medicaid (CMS) startingJanuary 2022. Based on the 2022 Clinical Diagnostic Laboratory Fee Schedule by CMS, healthcare...

2022-01-07 22:00 2363

Elekta to appoint Tobias Hägglöv as Chief Financial Officer

STOCKHOLM, Jan. 7, 2022 /PRNewswire/ -- Elekta (STO: EKTA-B) announced today that it will appoint Tobias Hägglöv as Chief Financial Officer effective February 1, 2022, taking over from Johan Adebäck. Tobias Hägglöv has previously held the role of CFO at Recipharm as well as senior management posit...

2022-01-07 14:49 1875

Infinitus Wins Best Companies to Work for in Asia Award

GUANGZHOU, China, Jan. 7, 2022 /PRNewswire/ -- On December 30, human resources magazine HR Asia announced its list of the Best Companies to Work for inAsia 2021. Infinitus (China) Company Ltd., along with 42 companies including KPMG, Kimberly-Clark and Coach, were selected from 278 candidates to...

2022-01-07 10:20 2898

Infinitus Wins Best Companies to Work for in Asia Award

Insilico Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference

HONG KONG and NEW YORK, Jan. 7, 2022 /PRNewswire/ -- Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, will virtually participate in the 40th Annual J.P. Morgan Healthcare Conference.Alex Zhavoronkov, Founder and Chief Executive Officer of I...

2022-01-07 03:55 2117

Emma by AXA users can enjoy 90-day free sports care protection

HONG KONG, Jan. 6, 2022 /PRNewswire/ -- AXA Hong Kong supports customers to achieve their health goals and fight the pandemic with strong physique in 2022. Emma by AXA, our all-in-one insurance & health services platform, is now offering "Free AXA SportCare Programme" to the public. From now unti...

2022-01-06 14:53 2250

Virtue Diagnostics closes $100 million Series B Funding

SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- Virtue Diagnostics, an innovative IVD company, has just announced closingUS$100 million in Series B funding. Virtue Diagnostics, founded in 2019, is focused on clinical tests forChina and emerging markets. SequoiaChina and Morningside Ventures jointly led th...

2022-01-06 11:01 3698

DiscGenics to Present at 40th Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY, Jan. 6, 2022 /PRNewswire/ -- DiscGenics, Inc., a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that Chie...

2022-01-06 09:05 2279

MingMed to Present at the 40th Annual J.P. Morgan Healthcare Conference

GUANGZHOU, China, Jan. 6, 2022 /PRNewswire/ -- MingMed Biotechnology, a clinical stage company dedicated to developing First-in-Class pharmaceutical products, today announced that Ms.Liza Ko, Chief Financial Officer of the company, has been invited to present at the 40th Annual J.P. Morgan Health...

2022-01-06 09:00 2732

MingMed to Present at the 40th Annual J.P. Morgan Healthcare Conference

CSafe Global Launches Real-Time Shipment Visibility for Passive Portfolios

CSafe now offers real-time visibility and online ordering for VIP Parcel and Cell & Gene Solutions. DAYTON, Ohio, Jan. 6, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today it has expanded its real-time...

2022-01-06 00:01 2766

CSafe Global Launches Real-Time Shipment Visibility for Passive Portfolios

Tools4Patient Announces Name Change to Cognivia & Expands Board of Directors

MONT-SAINT-GUIBERT, Belgium, Jan. 5, 2022 /PRNewswire/ -- Cognivia today announced a new name for the company formerly known as Tools4Patient, which provides clinical trials solutions based on AI / ML that account for individual patient personality traits, beliefs and perceptions. The transition ...

2022-01-05 23:00 2142

1 ... 242 243 244245246 247 248 ... 554